Endpoint definition
↥| Name | G6_CONDEVMYA |
|---|---|
| Long name | Congenital and developmental myasthenia |
| Hospital Discharge registry | ICD-10: G702 |
| Cause of Death registry | ICD-10: G702 |
| Level in the ICD-hierarchy | 3 |
| First defined in version | DF2 |
Congenital and developmental myasthenia
Myasthenia gravis: Myasthenia gravis (MG) is a rare, clinically heterogeneous, autoimmune disorder of the neuromuscular junction characterized by fatigable weakness of voluntary muscles.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 14 | 8 | 6 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 56.51 | 47.93 | 67.95 |
| Case fatality at 5-years (%) | 7.14 | 0.00 | 16.67 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.5 |
| Recurrence at 6 months (%) | 14.29 | - | 33.33 |
Survival analyses between endpoints
↥Plot
before Congenital and developmental myasthenia
after Congenital and developmental myasthenia
Loading survival analyses plot…
Table
Loading survival analyses table…